Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 29,684 shares of IOVA stock, worth $165,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,684
Previous 25,492
16.44%
Holding current value
$165,043
Previous $239,000
8.37%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding IOVA
# of Institutions
339Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$153 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$136 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$123 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$68.1 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $877M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...